Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
AS-22 is a hypertonic, non-specific MMP-inhibiting, hydrating & cleaning solution to treat bedsores, diabetic ulcers, and venous leg ulcers. Reduces pain and promotes fast healing, even in case of refractory wounds More
Collagen-based dressings for wound management More
EGT022 (human derived recombinant polypeptide) / Pressure sore More
Collagen-based biodegradable matrices for localized drug delivery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2011 - 90 pages - $2,000
Dec 2010 - 33 pages - $500
Nov 2010 - 217 pages - $1,495
Apr 2011 - 43 pages - $500
Aug 2011 - 45 pages - $500
May 2011 - 37 pages - $1,000
Jan 2011 - 20 pages - $500
Mar 2011 - 18 pages - $500
Mar 2011 - 53 pages - $500
Oct 2011 - 17 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us